Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test case

Currently, no formal mechanisms or systematic approaches exist to inform developers of new vaccines of the evidence anticipated to facilitate global policy recommendations, before a vaccine candidate approaches regulatory approval at the end of pre-licensure efficacy studies. Consequently, significa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kochhar, Sonali, Barreira, Draurio, Beattie, Pauline, Cavaleri, Marco, Cravioto, Alejandro, Frick, Mike W., Ginsberg, Ann M., Hudson, Ian, Kaslow, David C., Kurtz, Sherry, Lienhardt, Christian, Madhi, Shabir A., Morgan, Christopher, Momeni, Yalda, Patel, Deepali, Rees, Helen, Rogalski-Salter, Taryn, Schmidt, Alexander, Semete-Makokotlela, Boitumelo, Voss, Gerald, White, Richard G, Zignol, Matteo, Giersing, Birgitte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2022
Materias:
Conference Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914344/
https://www.ncbi.nlm.nih.gov/pubmed/35164990
http://dx.doi.org/10.1016/j.vaccine.2021.10.062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914344/
https://www.ncbi.nlm.nih.gov/pubmed/35164990
http://dx.doi.org/10.1016/j.vaccine.2021.10.062

Ejemplares similares